Phase 2 trial shows daridorexant boosts pediatric insomnia sleep time up to 50 minutes, including ADHD/ASD patients, with strong safety and phase 3 plans.
|Slideshows|June 2, 2020
Sleep Hygiene Tips to Prevent Insomnia
Author(s)Sharon Packer, MD
Refreshed sleep can be tough even during normal times. With up to 30% of Americans experiencing sleep problems, here are guidelines to a better night’s sleep.
Advertisement
Advertisement
Related to this article
Sleep disruption fuels Alzheimer risk via apnea, fragmentation, and inflammation; improving consolidated sleep, medication review, and sleep-specialist teamwork may protect cognition.
Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
Seaport begins phase 2a trial of GlyphAgo for generalized anxiety disorder with sleep disturbance, testing liver-sparing agomelatine dosing and tracking sleep, anxiety outcomes.
Advertisement
Advertisement
Trending on Psychiatric Times
1
MDD Side Effect Profiles: Counseling, Adherence, and Suicidality Monitoring
2
Daridorexant, Orexin Receptor Agonist, Shows Positive Results in Pediatric Insomnia
3
Synapse-Level Mapping Could Reveal How Disrupted Brain Circuits Lead to Psychiatric Disorders
4
Sleep Disruption and Alzheimer Disease: A Bidirectional, Treatable Relationship
5